BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 22314337)

  • 21. Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML.
    Koenecke C; Kümpers P; Lukasz A; Dammann E; Verhagen W; Göhring G; Buchholz S; Krauter J; Eder M; Schlegelberger B; Ganser A
    Ann Hematol; 2010 May; 89(5):459-67. PubMed ID: 20054548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation.
    Wölfel C; Lennerz V; Lindemann E; Hess G; Derigs HG; Huber C; Herr W; Wölfel T
    Cancer Immunol Immunother; 2008 Jun; 57(6):849-57. PubMed ID: 18004563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity.
    Ando T; Mitani N; Matsui K; Yamashita K; Nomiyama J; Tsuru M; Yujiri T; Tanizawa Y
    Int J Hematol; 2009 Oct; 90(3):374-377. PubMed ID: 19629629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
    Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
    Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
    Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
    Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation.
    Villalobos IB; Takahashi Y; Akatsuka Y; Muramatsu H; Nishio N; Hama A; Yagasaki H; Saji H; Kato M; Ogawa S; Kojima S
    Blood; 2010 Apr; 115(15):3158-61. PubMed ID: 20124217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not available.
    Appelbaum FR
    Hematology Am Soc Hematol Educ Program; 2008; ():412-7. PubMed ID: 19074118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case report of the second de novo acute myeloid leukemia (AML) following allogeneic stem cell transplantation in a patient with the first AML.
    Cho BS; Kim HJ; Eom KS; Lee JW; Min WS; Kim CC
    Korean J Intern Med; 2010 Mar; 25(1):110-3. PubMed ID: 20195413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcome.
    Fraccaroli A; Vogt D; Rothmayer M; Spiekermann K; Pastore F; Tischer J
    Ann Hematol; 2023 Aug; 102(8):2213-2223. PubMed ID: 37300568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric acute myeloid leukemia patients with
    Yang W; Qin M; Jia C; Yang J; Chen W; Luo Y; Jing Y; Wang B
    Hematology; 2022 Dec; 27(1):583-589. PubMed ID: 35617149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism.
    Bertaina A; Andreani M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29470425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of Severe Aplastic Anemia into Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Rare Case Report.
    Wang Q; Xu H; Yu W; Sun L; Zhao H; Shi X
    Am J Case Rep; 2024 Apr; 25():e943801. PubMed ID: 38632857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray.
    Hoves S; Aigner M; Pfeiffer C; Laumer M; Obermann EC; Mackensen A
    Leukemia; 2009 May; 23(5):877-85. PubMed ID: 19148137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
    Tokaz MC; Baldomero H; Cowan AJ; Saber W; Greinix H; Koh MBC; Kröger N; Mohty M; Galeano S; Okamoto S; Chaudhri N; Karduss AJ; Ciceri F; Colturato VAR; Corbacioglu S; Elhaddad A; Force LM; Frutos C; León AG; Hamad N; Hamerschlak N; He N; Ho A; Huang XJ; Jacobs B; Kim HJ; Iida M; Lehmann L; de Latour RP; Percival MM; Perdomo M; Rasheed W; Schultz KR; Seber A; Ko BS; Simione AJ; Srivastava A; Szer J; Wood WA; Kodera Y; Nagler A; Snowden JA; Weisdorf D; Passweg J; Pasquini MC; Sureda A; Atsuta Y; Aljurf M; Niederwieser D
    Transplant Cell Ther; 2023 Apr; 29(4):279.e1-279.e10. PubMed ID: 36572384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic evolution predicts a poor prognosis in acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation.
    Li R; Wang Z; Zhang Y; Guo M; Ni X; Chen J; Chen L; Gao L; Gong S; Tang G; Yang J; Wang J
    Ann Hematol; 2023 Jan; 102(1):89-97. PubMed ID: 36542104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation.
    Pagliuca S; Gurnari C; Hercus C; Hergalant S; Hong S; Dhuyser A; D'Aveni M; Aarnink A; Rubio MT; Feugier P; Ferraro F; Carraway HE; Sobecks R; Hamilton BK; Majhail NS; Visconte V; Maciejewski JP
    Nat Commun; 2023 May; 14(1):3153. PubMed ID: 37258544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extramedullary relapse of AML with t(9;11)(p22;q23) associated with clonal evolution from trisomy 8 into tetrasomy 8.
    Takahashi T; Tsukuda H; Kimura H; Yoshimoto M; Tsujisaki M
    Intern Med; 2010; 49(5):447-51. PubMed ID: 20190481
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.